Vera Ignjatović: Why Is Thrombosis Research So Far Behind When It Comes to AI and Multi-Omics?
Vera Ignjatović, Founder and Managing Director at Ignis Innovations Pty Ltd, Principal Consultant of Translational Research at Johns Hopkins All Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH Journal, adding:
”I am excited to share a paper co-authored with my colleagues Steven Bruzek, MS, MB(ASCP), Grant Vestal, and Neil Goldenberg, MD PhD just published in RPTH Journal that asks a question our field (thrombosis) really needs to sit with.
Why is thrombosis research so far behind when it comes to AI and multi-omics?
Our paper focuses on:
- Multi-omics (genomics, proteomics, metabolomics, etc.) is already transforming cancer and cardiovascular research.
- AI helps researchers make sense of massive, complex datasets that would otherwise be difficult to analyze.
- But in thrombosis research? Only FOUR studies have ever used AI with multi-omics.
That gap represents a problem, but also a great opportunity!
Blood clots kill.
Deep vein thrombosis, pulmonary embolism, and stroke are not rare events, particularly not in adults, and hospitalized children.
We have the tools to better predict, diagnose, and treat blood clots.
We are simply not (yet) using them broadly in this field.
In this paper, we are calling on the thrombosis community to step up.
Specifically, more collaboration, more training, more data sharing, and more investment in the next generation of researchers who can bridge the gap between biology and data science.
I am genuinely passionate about this space.”
Title: Artificial Intelligence (AI)-Empowered, Clinically-Integrated Multi-Omics Research in Thrombosis: A Call to Action
Authors: Steven Bruzek, Grant Vestal, Neil Goldenberg, Vera Ignjatovic
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience